DIMA Biotechnology
DIMA Biotechnology is a biotechnology company dedicated to antibody drug discovery and functional full-length membrane protein development, with particular expertise in GPCR and ion channel targets. We offer the world’s largest in-stock collection of full-length, functional GPCR proteins in Nanodisc format, with 500+ GPCR targets available for next day delivery. Our GPCR nanodisc products have been widely used in diverse downstream applications, including ligand binding, antibody discovery, assay development, and Cryo-EM structural studies, etc.
In parallel, DIMA’s DimAb® single B monoclonal antibody development platform has generated several hundred druggable lead monoclonal antibodies against 40+ GPCR targets. By combining advanced GPCR nanodisc platforms with mAb discovery technologies, DIMA Biotech helps Biopharma researchers accelerate GPCR research and antibody drug discovery.
